Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner News Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves News Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement News Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity News AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints News Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints
Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy News Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy
Nucleus RadioPharma CEO Chuck Conroy featured In C&EN article: Investment grows in radiopharma manufacturing News Nucleus RadioPharma CEO Chuck Conroy featured In C&EN article: Investment grows in radiopharma manufacturing
Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment News Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials News CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials News ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
